Raoul S. Concepcion, MD, FACS | Authors

Articles

Assessing the Role of Darolutamide in CRPC

February 15, 2019

Raoul S. Concepcion, MD, FACS, director, Comprehensive Prostate Center, discusses takeaways from the ARAMIS study of darolutamide in patients with nonmetastatic castration-resistant prostate cancer.